In vivo changes in the rectal values of eicosanoid inflammatory mediators induced by pelvic radiotherapy were measured to study the pathophysiology of the early radiation bowel reaction. Ten patients having pelvic radiotherapy, aged 57 to 78, had rectal dialysis. Values of the eicosanoids leukotriene B4 (LTB4), thromboxane B2 (TXB2), and prostaglandin E2 (PGE2) were measured before radiotherapy, at the end of radiotherapy, and at least four weeks after radiotherapy. Values of LTB4 rose with radiotherapy from 0-21 ng.ml-1 (median) to 1-14 ng.ml-1 (p=0012); PGE2 rose from 0-60 ng.ml-P to 1*58 ng.ml-1 (p=0038), and TXB2 rose from 0*365 ng.ml-1 to 1-6 ng.ml-1 (p=0005). The rise in eicosanoid inflammatory mediators may have an important role in the pathophysiology of the early radiation bowel reaction. (Gut 1993; 34: 1210-1214 The early radiation bowel reaction occurs in radiotherapy to the pelvis in up to 75% of patients treated.' 2 This normal tissue injury is a limiting factor for radiotherapy dose. The early reaction is associated with symptoms of diarrhoea and nausea3 and histologically is characterised by an inflammatory cell infiltrate, oedema, ulceration, epithelial cell loss, congestion, and nuclear damage.4
The early radiation bowel reaction occurs in radiotherapy to the pelvis in up to 75% of patients treated.' 2 This normal tissue injury is a limiting factor for radiotherapy dose. The early reaction is associated with symptoms of diarrhoea and nausea3 and histologically is characterised by an inflammatory cell infiltrate, oedema, ulceration, epithelial cell loss, congestion, and nuclear damage. 4 The cellular mechanisms underlying this reaction are not clearly understood; they probably entail the triggering of inflammatory reactions by the release of reactive species generated by ionising radiation. Eicosanoid inflammatory mediators include the oxidative products of arachidonic acid prostaglandin E2 (PGE2), thromboxane A2(TXA2), and leukotriene B4 (LTB4). Eicosanoid mediators of inflammation are raised in animal models of radiation injury to the gut. 5 We have investigated the mechanism of the early radiation bowel reaction in vivo in humans by measuring changes in rectal dialysate values of PGE2, LTB4, and TXB4 (the stable product of TXA2).
Methods DESIGN because patients are able to tolerate it well and variable early expulsion is avoided. Dialysis was performed at the same time of day for each subject. Unextracted samples were stored at -40°C and samples extracted into methanol were stored at -20°C. Samples from individual subjects were assayed together.
RADIOIMMUNOASSAY OF EICOSANOIDS
Dialysates were assayed by radioimmunoassay. The assays were validated against high performance liquid chromatography (HPLC) for the LTB4 assay and against gas chromatography and mass spectrometry (GCMS)' for the TXB2 and PGE2 assay.
LTB4
Samples were extracted for LTB4 assay. One ml of rectal dialysate sample was mixed with 1 ml of HPLC grade methanol (Fisons). This precipitated out the dextran which was spun down at 3500 rpm at 4°C for 10 minutes. Samples of each supernatant (1-67 ml) were taken and acidified to pH 4 with 0 5% trifluoroacetic acid (Sigma) using an autotitrator (Radiometer, Copenhagen (Fig 1) . Dialysates from patients with ulcerative colitis were assayed both by GCMS and by radioimmunoassays. For PGE2 (Fig 2) and TXB2 (Fig 3) Figure 4 shows the results for LTB4. There is a consistent and significant rise in the LTB4 from 0-21 (median, range 0-20 to 0 64) before radiotherapy to 1-14 (0-20 to 4 0) after radiotherapy (median rise 0-89 ng.ml-1, p=0-012). In those subjects studied again at four to eight weeks after radiotherapy LTB4 values fell by 1 ng.ml '(0 to -1-6, p=0028).
TXB rose after radiotherapy from 0-36 ng.ml-(0 10 to 0 88) before radiotherapy to 1-6 (0-26 to 3-28, (median rise 125 ng.ml ' (p= 0 005)) and then fell four weeks after radiotherapy stopped by 1-33 ng.ml ' (+0 05 to -3-01, p=0028) (Fig 5) . PGE2 rose after radiotherapy from 0-6 ng.ml- ' ng.ml-1 (median 0 60 to 9 6) with a median rise of 0 44 ng.ml-1, p=0038) and then fell by -048 ng.ml-I (median, range +0 92 to -1I56, p=0 173) (Fig 6) .
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